Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-23-020112

Director bought 7,000 shares at $1.46 ($10,220)

From the SEC's structured data for this filing

Trades in this filing

Rubin Steven D · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-05-25 Purchase : show line 1 in the form +7,000 $1.46 $10,220 7,000 D
Open-market purchases · 7,000 sh · avg $1.46 · $10,220
Loading xslF345X04/wk-form4_1685477593.xml…